Nfatc2 and Tob1 have non-overlapping function in T cell negative regulation and tumorigenesis
Sarah L May,Qing Zhou,Mitzi Lewellen,Cristan M Carter,David Coffey,Steven L Highfill,Christoph M Bucher,Ilze Matise,Herbert C Morse 3rd,M Gerard O'Sullivan,Melissa Schutten,Charles Johnson,Donald Bellgrau,Bruce R Blazar,Jaime F Modiano
DOI: https://doi.org/10.1371/journal.pone.0100629
IF: 3.7
2014-06-19
PLoS ONE
Abstract:Nfatc2 and Tob1 are intrinsic negative regulators of T cell activation. Nfatc2-deficient and Tob1-deficient T cells show reduced thresholds of activation; however, whether these factors have independent or overlapping roles in negative regulation of T cell responses has not been previously examined. Here, we show that Nfatc2 knockout (KO) but not Tob1 KO mice have age-associated accumulation of persistently activated T cells in vivo and expansion of the CD44+ memory cell compartment and age-associated lymphocytic infiltrates in visceral organs, without significant changes in numbers of CD4+CD25+Foxp3+ regulatory T cells (Treg). In vitro, CD4+CD25- "conventional" T cells (Tconvs) from both KO strains showed greater proliferation than wild type (WT) Tconvs. However, while Tregs from Nfatc2 KO mice retained normal suppressive function, Tregs from Tob1 KOs had enhanced suppressive activity. Nfatc2 KO Tconvs expanded somewhat more rapidly than WT Tconvs under conditions of homeostatic proliferation, but their accelerated growth capacity was negated, at least acutely, in a lymphoreplete environment. Finally, Nfatc2 KO mice developed a previously uncharacterized increase in B-cell malignancies, which was not accelerated by the absence of Tob1. The data thus support the prevailing hypothesis that Nfatc2 and Tob1 are non-redundant regulators of lymphocyte homeostasis.